Annual Operating Expenses
$7.31 M
-$3.80 M-34.23%
June 30, 2024
Summary
- As of February 25, 2025, ESLA annual total operating expenses is $7.31 million, with the most recent change of -$3.80 million (-34.23%) on June 30, 2024.
- During the last 3 years, ESLA annual operating expenses has risen by +$6.58 million (+896.33%).
- ESLA annual operating expenses is now -34.23% below its all-time high of $11.11 million, reached on June 1, 2023.
Performance
ESLA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.38 M
-$572.70 K-14.50%
September 30, 2024
Summary
- As of February 25, 2025, ESLA quarterly total operating expenses is $3.38 million, with the most recent change of -$572.70 thousand (-14.50%) on September 30, 2024.
- Over the past year, ESLA quarterly operating expenses has stayed the same.
- ESLA quarterly operating expenses is now -14.50% below its all-time high of $3.95 million, reached on June 30, 2024.
Performance
ESLA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ESLA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.2% | 0.0% |
| 3 y3 years | +896.3% | +17.0% |
| 5 y5 years | +896.3% | +17.0% |
ESLA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.2% | +896.3% | -14.5% | +3088.6% |
| 5 y | 5-year | -34.2% | +896.3% | -14.5% | +3088.6% |
| alltime | all time | -34.2% | +896.3% | -14.5% | +3088.6% |
Estrella Immunopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.38 M(-14.5%) |
| Jun 2024 | $7.31 M(-34.2%) | $3.95 M(+741.2%) |
| Mar 2024 | - | $469.50 K(-54.0%) |
| Dec 2023 | - | $1.02 M(-45.4%) |
| Sep 2023 | - | $1.87 M(-31.5%) |
| Jun 2023 | - | $2.73 M(-0.4%) |
| Jun 2023 | $11.11 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.74 M(-0.6%) |
| Dec 2022 | - | $2.76 M(-4.5%) |
| Sep 2022 | - | $2.89 M(+168.6%) |
| Jun 2022 | - | $1.07 M(+538.3%) |
| Jun 2022 | $1.69 M(+129.7%) | - |
| Mar 2022 | - | $168.30 K(+58.9%) |
| Dec 2021 | - | $105.90 K |
| Jun 2021 | $733.70 K | - |
FAQ
- What is Estrella Immunopharma annual total operating expenses?
- What is the all time high annual operating expenses for Estrella Immunopharma?
- What is Estrella Immunopharma annual operating expenses year-on-year change?
- What is Estrella Immunopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly operating expenses year-on-year change?
What is Estrella Immunopharma annual total operating expenses?
The current annual operating expenses of ESLA is $7.31 M
What is the all time high annual operating expenses for Estrella Immunopharma?
Estrella Immunopharma all-time high annual total operating expenses is $11.11 M
What is Estrella Immunopharma annual operating expenses year-on-year change?
Over the past year, ESLA annual total operating expenses has changed by -$3.80 M (-34.23%)
What is Estrella Immunopharma quarterly total operating expenses?
The current quarterly operating expenses of ESLA is $3.38 M
What is the all time high quarterly operating expenses for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly total operating expenses is $3.95 M
What is Estrella Immunopharma quarterly operating expenses year-on-year change?
Over the past year, ESLA quarterly total operating expenses has changed by $0.00 (0.00%)